4UBI:XETRA:XETRA-UBS (Irl) ETF plc - MSCI USA Socially Responsible UCITS ETF (USD) A-acc (EUR)

ETF | Others |

Last Closing

USD 19.584

Change

+0.39 (+2.04)%

Market Cap

USD 0.37B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.77 (-1.46%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.40 (-1.38%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.38 (-1.37%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.39 (-1.54%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.78 (-1.67%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-2.26 (-1.55%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.73 (-1.40%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.36 (-0.34%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.36 (+0.06%)

USD 80.38B

ETFs Containing 4UBI:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 28.76% 88% B+ 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.76% 88% B+ 87% B+
Trailing 12 Months  
Capital Gain 38.70% 89% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.70% 89% A- 88% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.99% 68% D+ 67% D+
Dividend Return 9.99% 67% D+ 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.18% 51% F 61% D-
Risk Adjusted Return 82.06% 78% C+ 81% B-
Market Capitalization 0.37B 59% D- 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike